Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)
Clinical trial NCT01460342 · COMPLETED
Trial details
- NCT number
- NCT01460342
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-10-01
- Enrollment
- 610
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.